Deutsche Bank’s ClearPoint Neuro CLPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.36M Sell
111,786
-3,009
-3% -$45.2K ﹤0.01% 2017
2026
Q2
$2.05M Sell
114,795
-116,146
-50% -$1.45M ﹤0.01% 1895
2026
Q1
$2.1M Buy
230,941
+2,808
+1% +$35.5K ﹤0.01% 1746
2025
Q4
$3.12M Sell
228,133
-4,154
-2% -$77K ﹤0.01% 1537
2025
Q3
$5.06M Buy
232,287
+206,901
+815% +$2.44M ﹤0.01% 1304
2025
Q2
$303K Buy
25,386
+20,080
+378% +$253K ﹤0.01% 2728
2025
Q1
$63.1K Buy
+5,306
New +$82.5K ﹤0.01% 3330
2024
Q2
– Sell
-19,076
Closed -$130K – 3587
2024
Q1
$130K Sell
19,076
-559
-3% -$3.91K ﹤0.01% 3046
2023
Q4
$133K Sell
19,635
-6,278
-24% -$35.5K ﹤0.01% 3085
2023
Q3
$130K Buy
+25,913
New +$154K ﹤0.01% 3040
2022
Q3
– Sell
-4,951
Closed -$65K – 3986
2022
Q2
$65K Sell
4,951
-6,336
-56% -$64.7K ﹤0.01% 3680
2022
Q1
$118K Sell
11,287
-1,220
-10% -$11.1K ﹤0.01% 3524
2021
Q4
$141K Buy
12,507
+602
+5% +$9.01K ﹤0.01% 3543
2021
Q3
$211K Sell
11,905
-264
-2% -$4.95K ﹤0.01% 3543
2021
Q2
$232K Buy
+12,169
New +$235K ﹤0.01% 3701

Other funds holding CLPT

Deutsche Bank's CLPT Position: Q3 2026 in Review

Deutsche Bank reduced its ClearPoint Neuro (CLPT) stake by 2.6% in Q3 2026, selling an estimated $45.2K and leaving 111,786 shares worth $1.36M. The position accounts for ﹤0.01% of the portfolio, ranked #2017.

Deutsche Bank first reported a position in CLPT in Q2 2021 and has held it in 15 quarters since. The position peaked at $5.06M in Q3 2025. 45 funds tracked by Wall St. Rank hold CLPT as of Q3 2026.

  • Deutsche Bank held 111,786 shares of ClearPoint Neuro worth $1.36M as of Q3 2026.
  • Deutsche Bank sold 3,009 ClearPoint Neuro shares in Q3 2026, an estimated $45.2K.
  • ClearPoint Neuro made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #2017 holding.
  • Deutsche Bank first reported a position in ClearPoint Neuro in Q2 2021 and has held it in 15 quarters since.
  • Deutsche Bank's ClearPoint Neuro position peaked at $5.06M in Q3 2025.
  • 45 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q3 2026.

Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.